CCR7+ selected gene-modified T cells maintain a central memory phenotype and display enhanced persistence in peripheral blood in vivo
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CCR7+ selected gene-modified T cells maintain a central memory phenotype and display enhanced persistence in peripheral blood in vivo
Authors
Keywords
CCR7, CD62L, Adoptive cell therapy, Immunotherapy, Differentiation status, Transgenic TCR, Central memory, DMF5
Journal
Journal for ImmunoTherapy of Cancer
Volume 5, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-02-10
DOI
10.1186/s40425-017-0216-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A drive through cellular therapy for CLL in 2015: allogeneic cell transplantation and CARs
- (2015) A. Mato et al. BLOOD
- Generation of memory T cells for adoptive transfer using clinical-grade anti-CD62L magnetic beads
- (2015) S Verfuerth et al. BONE MARROW TRANSPLANTATION
- CAR T-cell therapy: toxicity and the relevance of preclinical models
- (2015) Milena Kalaitsidou et al. Immunotherapy
- Cytokine profiles amongst Sudanese patients with visceral leishmaniasis and malaria co-infections
- (2014) Erika van den Bogaart et al. BMC IMMUNOLOGY
- Adoptive Therapy With Chimeric Antigen Receptor–Modified T Cells of Defined Subset Composition
- (2014) Stanley R. Riddell et al. CANCER JOURNAL
- Relation of clinical culture method to T-cell memory status and efficacy in xenograft models of adoptive immunotherapy
- (2014) David M. Barrett et al. CYTOTHERAPY
- “Do you catch my drift?”
- (2014) Timothy Hannon TRANSFUSION
- Tissue-Specific Attenuation of Oncolytic Sindbis Virus Without Compromised Genetic Stability
- (2014) Gray Kueberuwa et al. Human Gene Therapy Methods
- Definition and application of good manufacturing process-compliant production of CEA-specific chimeric antigen receptor expressing T-cells for phase I/II clinical trial
- (2013) Ryan D. Guest et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Humanized NOD-SCID IL2rg –/– mice as a preclinical model for cancer research and its potential use for individualized cancer therapies
- (2013) Qianjun Zhou et al. CANCER LETTERS
- The who's who of T-cell differentiation: Human memory T-cell subsets
- (2013) Yolanda D. Mahnke et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors
- (2013) James N. Kochenderfer et al. Nature Reviews Clinical Oncology
- Potential Limitations of the NSG Humanized Mouse as a Model System to Optimize Engineered Human T cell Therapy for Cancer
- (2013) Erik M. Alcantar-Orozco et al. Human Gene Therapy Methods
- Sorting Through Subsets
- (2012) Christopher A. Klebanoff et al. JOURNAL OF IMMUNOTHERAPY
- Xenogeneic Graft-versus-Host-Disease in NOD-scid IL-2Rγnull Mice Display a T-Effector Memory Phenotype
- (2012) Niwa Ali et al. PLoS One
- Transferred melanoma-specific CD8+ T cells persist, mediate tumor regression, and acquire central memory phenotype
- (2012) A. G. Chapuis et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Decade-Long Safety and Function of Retroviral-Modified Chimeric Antigen Receptor T Cells
- (2012) J. Scholler et al. Science Translational Medicine
- Determinants of Successful CD8 + T-Cell Adoptive Immunotherapy for Large Established Tumors in Mice
- (2011) Christopher A. Klebanoff et al. CLINICAL CANCER RESEARCH
- SPICE: Exploration and analysis of post-cytometric complex multivariate datasets
- (2011) Mario Roederer et al. CYTOMETRY PART A
- Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1
- (2011) Paul F. Robbins et al. JOURNAL OF CLINICAL ONCOLOGY
- Early events governing memory CD8+ T-cell differentiation
- (2010) J. J. Obar et al. INTERNATIONAL IMMUNOLOGY
- T Cells Targeting Carcinoembryonic Antigen Can Mediate Regression of Metastatic Colorectal Cancer but Induce Severe Transient Colitis
- (2010) Maria R Parkhurst et al. MOLECULAR THERAPY
- Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen
- (2009) L. A. Johnson et al. BLOOD
- Immunotherapy of Metastatic Melanoma Using Genetically Engineered GD2-Specific T cells
- (2009) E. Yvon et al. CLINICAL CANCER RESEARCH
- Cellular and molecular mechanisms of memory T-cell survival
- (2009) Andre Tanel et al. Expert Review of Vaccines
- Adoptively transferred effector cells derived from naive rather than central memory CD8+ T cells mediate superior antitumor immunity
- (2009) C. S. Hinrichs et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Biochemical signaling pathways for memory T cell recall
- (2009) Donna L. Farber SEMINARS IN IMMUNOLOGY
- Differential expression of CCR7 defines two distinct subsets of human memory CD4+CD25+ Tregs
- (2008) Valeria Tosello et al. CLINICAL IMMUNOLOGY
- The effect of artificial antigen-presenting cells with preclustered anti-CD28/-CD3/-LFA-1 monoclonal antibodies on the induction of ex vivo expansion of functional human antitumor T cells
- (2008) R. Zappasodi et al. HAEMATOLOGICA
- Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates
- (2008) Carolina Berger et al. JOURNAL OF CLINICAL INVESTIGATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search